Goddard Glenn
CIK 0001581992
EVP, Chief Financial Officer
Filings
8
Latest Mar 5, 2024
Issuers covered
1
Showing
8 of 8
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 67% | +7.9% | +14.2% | +19.8% | -10.5% |
| 90 days | 3 | 100% | +19.5% | +14.9% | +36.0% | +7.5% |
| 180 days | 3 | 67% | +22.2% | +23.8% | +46.9% | -4.0% |
| 365 days | 3 | 100% | +51.3% | +58.6% | +70.9% | +24.6% |
Issuers
Companies where Goddard Glenn has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| NTLA | Intellia Therapeutics, Inc. | 8 | Mar 5, 2024 |
All filings
8 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|